RNA5SP503

Across TCGA pan-cancer cohorts, RNA5SP503 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNA5SP503 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RNA5SP503 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP503 expression acts as an unfavorable survival marker.

SKCM, KIRC, and KICH are the cancer types where RNA5SP503 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	IV	0.042	0.477	.001	105	view →
KIRC	DFS	Tertile	All	0.272	0.671	<.001	66	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
BRCA	OS	Tertile	III,IV	0.176	0.833	<.001	36	view →
PAAD	DFS	Tertile	All	0.235	0.476	.027	18	view →
BLCA	OS	Tertile	III,IV	0.141	0.581	.011	18	view →
THYM	DFS	Tertile	All	0.134	0.871	<.001	9	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
THCA	DFS	Tertile	All	0.051	0.811	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNA5SP503–SKCM (DFS)

Open the SKCM breakdown →